Treatments for Primary cutaneous peripheral T-cell lymphoma not otherwise specified

FDA-approved drugs, patient assistance programs, and travel grants tracked on UniteRare for this condition.

Treatment data is extracted from FDA drug labels, DailyMed, and openFDA through automated and AI-assisted pipelines that read both structured records and unstructured label text.
Report missing data

FDA-approved treatments (3)

Patient support programs (4)

Copay cards, manufacturer assistance, and foundation grants. Verification status shown on each card.

POLIVY

Genentech, Inc.

POLIVY Patient Support (Genentech Access Solutions)

Patient Assistance
Manufacturer Program
Accepting applications
Copay Card Apply

Beleodaq

Acrotech Biopharma LLC

Beleodaq Patient Support (Acrotech Patient Support)

Patient Assistance
Manufacturer Program
Accepting applications
Apply

Folotyn

Acrotech Biopharma LLC

Folotyn Patient Support (Acrotech Patient Support)

Patient Assistance
Manufacturer Program
Accepting applications
Apply

Ontak

Eisai, Inc.

Ontak — Contact Eisai, Inc.

Unverified — confirm before calling
Patient Assistance
Manufacturer Program
Accepting applications

More about Primary cutaneous peripheral T-cell lymphoma not otherwise specified